Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.2 USD | +1.28% | -15.23% | -18.81% |
Jun. 06 | Barclays Adjusts Price Target on Couchbase to $27 From $33, Maintains Equalweight Rating | MT |
Jun. 06 | UBS Adjusts Couchbase Price Target to $24 From $31, Maintains Neutral Rating | MT |
Valuation
Fiscal Period: Januar | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,021 | 668.1 | 1,202 | 904.1 | - | - |
Enterprise Value (EV) 1 | 925.7 | 499.8 | 1,048 | 757.9 | 751.3 | 740.8 |
P/E ratio | -9.89 x | -9.67 x | -14.7 x | -12.1 x | -14.1 x | -20.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.27 x | 4.32 x | 6.68 x | 4.36 x | 3.75 x | 3.17 x |
EV / Revenue | 7.49 x | 3.23 x | 5.82 x | 3.66 x | 3.12 x | 2.59 x |
EV / EBITDA | -21.7 x | -13.1 x | -36.3 x | -36 x | -74.7 x | 131 x |
EV / FCF | -21.8 x | -10.7 x | -33.2 x | -65.9 x | 141 x | 67.3 x |
FCF Yield | -4.58% | -9.37% | -3.02% | -1.52% | 0.71% | 1.48% |
Price to Book | 5.65 x | 4.47 x | 9.41 x | 7.99 x | 9.49 x | 9.57 x |
Nbr of stocks (in thousands) | 43,595 | 45,171 | 48,072 | 50,310 | - | - |
Reference price 2 | 23.43 | 14.79 | 25.00 | 17.97 | 17.97 | 17.97 |
Announcement Date | 3/9/22 | 3/7/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Januar | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 123.5 | 154.8 | 180 | 207.3 | 240.8 | 285.5 |
EBITDA 1 | - | -42.68 | -38.15 | -28.88 | -21.06 | -10.06 | 5.657 |
EBIT 1 | - | -45.51 | -41.32 | -31.31 | -23.59 | -13.76 | 4.266 |
Operating Margin | - | -36.84% | -26.69% | -17.39% | -11.38% | -5.71% | 1.49% |
Earnings before Tax (EBT) 1 | - | -57.21 | -67.46 | -78.83 | -74.72 | -64.84 | -50.66 |
Net income 1 | -39.98 | -58.23 | -68.49 | -80.18 | -77.14 | -71.09 | -57.22 |
Net margin | - | -47.13% | -44.24% | -44.54% | -37.21% | -29.52% | -20.04% |
EPS 2 | -7.700 | -2.370 | -1.530 | -1.700 | -1.487 | -1.275 | -0.8838 |
Free Cash Flow 1 | - | -42.39 | -46.83 | -31.6 | -11.51 | 5.333 | 11 |
FCF margin | - | -34.31% | -30.25% | -17.55% | -5.55% | 2.21% | 3.85% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 194.46% |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 6/21/21 | 3/9/22 | 3/7/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: January | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 35.06 | 34.85 | 39.79 | 38.56 | 41.62 | 41 | 43.14 | 45.81 | 50.09 | 51.33 | 51.13 | 50.63 | 54.28 | 57.1 | 58.69 |
EBITDA 1 | -8.371 | -12.67 | -7.632 | -8.791 | -9.065 | -12.06 | -8.474 | -4.631 | -3.725 | -6.297 | -4.642 | -5.372 | -4.782 | -4.8 | -3.173 |
EBIT 1 | -9.081 | -13.4 | -8.359 | -9.629 | -9.932 | -12.94 | -9.219 | -5.03 | -4.115 | -6.697 | -5.27 | -6.062 | -5.557 | -4.894 | -3.69 |
Operating Margin | -25.9% | -38.46% | -21.01% | -24.97% | -23.86% | -31.58% | -21.37% | -10.98% | -8.22% | -13.05% | -10.31% | -11.97% | -10.24% | -8.57% | -6.29% |
Earnings before Tax (EBT) 1 | -12.95 | -19.57 | -15 | -16.3 | -16.59 | -21.12 | -20.63 | -16.24 | -20.83 | -21.01 | -16.75 | -17.35 | -17.6 | -12.2 | -10.7 |
Net income 1 | -13.24 | -19.83 | -15.37 | -16.68 | -16.61 | -21.88 | -20.65 | -16.26 | -21.4 | -21 | -17.73 | -18.58 | -18.86 | -17.47 | -16.33 |
Net margin | -37.75% | -56.91% | -38.62% | -43.25% | -39.92% | -53.36% | -47.87% | -35.48% | -42.73% | -40.9% | -34.68% | -36.71% | -34.75% | -30.59% | -27.83% |
EPS 2 | -0.3000 | -0.4500 | -0.3400 | -0.3700 | -0.3700 | -0.4800 | -0.4400 | -0.3400 | -0.4400 | -0.4200 | -0.3566 | -0.3586 | -0.3562 | -0.3497 | -0.3228 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/9/22 | 6/8/22 | 9/7/22 | 12/6/22 | 3/7/23 | 6/6/23 | 9/6/23 | 12/6/23 | 3/5/24 | 6/5/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 95.7 | 168 | 154 | 146 | 153 | 163 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -42.4 | -46.8 | -31.6 | -11.5 | 5.33 | 11 |
ROE (net income / shareholders' equity) | - | -59.2% | -41.1% | -32% | -39.3% | -42.6% | -34.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 4.150 | 3.310 | 2.660 | 2.250 | 1.890 | 1.880 |
Cash Flow per Share 2 | - | -1.610 | -0.9200 | -0.5700 | -0.2700 | 0.1200 | - |
Capex 1 | - | 0.82 | 5.65 | 4.71 | 4.78 | 5.56 | 6.48 |
Capex / Sales | - | 0.66% | 3.65% | 2.62% | 2.3% | 2.31% | 2.27% |
Announcement Date | 6/21/21 | 3/9/22 | 3/7/23 | 3/5/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 904M | |
-37.57% | 103M |
- Stock Market
- Equities
- BASE Stock
- Financials Couchbase, Inc.